Hepatitis C patients 'in most critical need' selected for treatment as funds ran out

The HSE had to suspend its treatment programme for patients with Hepatitis C for a month in 2017 because it did not know the number of patients being treated and risked running out of money.

The programme was suspended at the end of July when the majority of its €30m budget had been used, according to report by the C&AG, published yesterday.